Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 35/100

Failure Rate

0.0%

0 terminated/withdrawn out of 3 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

50%

1 of 2 completed trials have results

Key Signals

1 with results

Enrollment Performance

Analytics

N/A
1(100.0%)
1Total
N/A(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (3)

Showing 3 of 3 trials
NCT06834178Not Yet Recruiting

Non-interventional Study to Assess the Number of People With Untreated/Unknown HBV + HDV and HCV in South-East Austria

Role: lead

NCT01182844Not ApplicableCompleted

Obesity - Inflammation - Metabolic Disease: Effect of Lactobacillus Casei Shirota

Role: lead

NCT01362569Completed

Endotoxin, Neutrophil Function and Albumin in Renal Insufficiency

Role: lead

All 3 trials loaded